Krensavage Asset Management, LLC

Position in EOLS — Evolus, Inc.

CIK 1609251 NEW YORK, NY

Back to EOLS Full portfolio

Position in EOLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$649,318

-$15,682 QoQ

Shares Held

157,985

+58.0% QoQ

Ownership

0.240%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $79,296,778 across 5 Drug Manufacturers - Specialty & Generic names. EOLS ranks #5 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	84,282	$49,977,540
2	SUPN	Supernus Pharmaceuticals, Inc.	280,681	$14,508,400
3	INDV	Indivior Pharmaceuticals, Inc.	339,532	$10,348,935
4	ALKS	Alkermes plc.	107,822	$3,812,585
5	EOLS	Evolus, Inc. This page	157,985	$649,318

All Filings in EOLS

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$649,318	157,985	+58.0%	Shares	Sole	2026-05-15
2025-12-31	$665,000	100,000	0.0%	Shares	Sole	2026-02-18
2025-09-30	$614,000	100,000	—	Shares	Sole	2025-11-17
No filing history on record for this holder in this stock.